12:00 AM
Sep 14, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

OVA1 test regulatory update

Vermillion received 510(k) clearance from FDA for its OVA1 test as an aid to assess the likelihood of ovarian cancer in women with...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >